Evidence map›Paper›PMID 29862310›Full record

ArticleTranslational issues in psychological science2017

Alterations in Hippocampal Activity and Alzheimer's Disease.

Sharay E Setti, Holly C Hunsberger, Miranda N Reed

Open access · hybridAbstract read
In one paragraph

Article in Translational issues in psychological science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Voltage-Gated NaLife (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Sex Differences in Cognition Across Aging.Current topics in behavioral neurosciences · 2023
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Morphological classification and changes in dementia (Review).Experimental and therapeutic medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sharay E SettiDepartment of Drug Discovery & Development, Auburn University.
Holly C HunsbergerDepartment of Psychiatry, Columbia University.
Miranda N ReedDepartment of Drug Discovery & Development, Auburn University.
Auburn University · USWest Virginia University · US

Funding

Determining the Roles of Aging and Extrasynaptic NMDARs in Tau Pathology.R15AG045812 · NIA · AUBURN UNIVERSITY AT AUBURN · PI REED, MIRANDA NICOLE · 2015 to 2015
$355k
NIA NIH HHS R15 AG045812
6 · The paper itself

Abstract

The aging population and those with amnestic mild cognitive impairment (aMCI) are at increased risk for developing Alzheimer's disease (AD). Individuals with aMCI in particular may display pathological changes in brain function that may ultimately result in a diagnosis of AD. This review focuses specifically on hippocampal hyperexcitability, a pathology that is sometimes detectable years before diagnosis, which has been observed in individuals with aMCI. We describe how changes in hippocampal activity are associated with, or in some cases may be permissive for, the development of AD. Finally, we describe how lifestyle changes, including exercise and dietary changes can attenuate cognitive decline and hippocampal hyperexcitability, potentially reducing the risk of developing AD.

Identifiers

PMID29862310
PMCPMC5972837
OpenAlexW2777711256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.